| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.26 | 0.08 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.51 | 0.09 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |